SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 93 of 100
Features
J&J brings in ethicists to judge on requests for experimental drugs
By
Reuters
May 7, 2015
Tech
Drugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal
By
Reuters
May 6, 2015
Features
Baltimore riots, Google, and Twitter earnings — 5 things to know today
By
Laura Lorenzetti
April 28, 2015
Leadership
How new blood in Washington, DC could impact the marijuana industry
By
Tom Huddleston Jr.
April 24, 2015
Finance
Mylan plays monkey-in-the-middle of hostile takeover battles
By
Jen Wieczner
April 22, 2015
Finance
Teva offers to buy rival Mylan for $40 billion to create generics giant
By
Laura Lorenzetti
April 21, 2015
Features
EU goes after Gazprom, and Teva eyes Mylan — 5 things to know today
By
Laura Lorenzetti
April 21, 2015
Tech
How one company is using artificial intelligence to develop a cure for cancer
By
Cyrus Sanati
April 16, 2015
Features
Americans spent a record amount on medicine in 2014
By
TIME
April 14, 2015
Finance
Hospira hit with further FDA scrutiny after $17 billion Pfizer deal
By
Laura Lorenzetti
April 8, 2015
Finance
Mylan goes big with $29 billion offer to buy Perrigo
By
Laura Lorenzetti
April 8, 2015
International
Pfizer to stop selling vaccines in China after failing to get license renewal
By
Reuters
and
Fortune Editors
April 2, 2015
International
Takeda’s ready to shell out $2.2 billion to settle Actos drug cases
By
Laura Lorenzetti
April 1, 2015
Retail
J&J, Glaxo settle U.S. lawsuit over allergy ads
By
Reuters
March 30, 2015
Finance
Dow gains 260 points as stock market jumps on news out of China
By
Tom Huddleston Jr.
March 30, 2015
Most Popular
AI
Meta's 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is 'vibe coding' right now
By
Eva Roytburg
Politics
First Tucker Carlson, now Ted Cruz: Conservatives are talking about an ‘unbelievably dangerous’ precedent being set by...
By
Nino Paoli
Economy
Ray Dalio says the world is running out of interest in buying U.S. debt—but America is unable to cut back its spending
By
Eleanor Pringle